SCHEMBL8653304

SCHEMBL8653304

COC(=O)c1c(F)c(F)c(OC)c(F)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.50
MEN1 O00255 7/20 0.50
CYP2C9 P11712 2/20 0.50
CYP1A2 P05177 1/20 0.50
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GFER P55789 2/20 0.46
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8593844 0.92 TSHR (0.46) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL8464230 0.90 KMT2A (0.53) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL27367262 0.86 TSHR (0.49) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL9766076 0.86 TSHR (0.52) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL8652422 0.86 TSHR (0.47) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL4247568 0.84 KMT2A (0.51) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL5702932 0.84 MEN1 (0.54) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL9766080 0.82 TSHR (0.44) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL28783675 0.82 KMT2A (0.48) KMT2AMEN1CYP2C9CYP1A2TSHR
SCHEMBL29154296 0.82 MEN1 (0.53) KMT2AMEN1CYP2C9CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010056633-A2 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2010-05-20 WO disclosed
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed
EP-0877011-A1 Processes for producing tetra-fluorophthalic anhydride and fluorobenzoic acids ASAHI GLASS COMPANY LTD. (JP) 1998-11-11 EP disclosed
EP-0866050-A1 Processes for producing tetra-fluorophthalic anhydride and fluorobenzioc acids ASAHI GLASS COMPANY LTD. (JP) 1998-09-23 EP disclosed
US-5648504-A MULTISTAGE PROCESS WITH CHLORINATION OF TETRACHLOROPHTHALIC ANHYDRIDE TO 3,3,4,5,6,7-HEXACHLORO-1-(3H)-ISOBENZOFURANONE THEN FLUORINATION AND REACTING WITH INORGANIC BASE OR ACID ASAHI GLASS COMPANY LTD. (JP) 1997-07-15 US disclosed
US-5523476-A Processes for producing tetrafluorophthalic anhydride and fluorobenzoic acids ASAHI GLASS COMPANY LTD. (JP) 1996-06-04 US disclosed
EP-0669310-A1 Processes for producing tetrafluorophtahlic anhydride and fluorobenzoic acids ASAHI GLASS COMPANY LTD. (JP) 1995-08-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES NQO2, QRFPR, NQO1 KMT2A 1652/4885MEN1 1904/4885CYP2C9 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.